60 related articles for article (PubMed ID: 34453786)
1. Determination of a CD4+CD25+ Foxp3+T cells subset in Egyptian Colorectal Cancer Patients.
Elsheshtawy NM; Saad M; El-Ghamrini YM; Ziada KW
Egypt J Immunol; 2021 Jul; 28(3):145-156. PubMed ID: 34453786
[TBL] [Abstract][Full Text] [Related]
2. Aberrant peripheral blood CD4
Dehghani M; Kalani M; Golmoghaddam H; Ramzi M; Arandi N
Cancer Immunol Immunother; 2020 Sep; 69(9):1917-1928. PubMed ID: 32385519
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25highFoxP3+ regulatory T-cells in hematologic diseases.
Moon HW; Kim BH; Park CM; Hur M; Yun YM; Kim SY; Lee MH
Korean J Lab Med; 2011 Oct; 31(4):231-7. PubMed ID: 22016675
[TBL] [Abstract][Full Text] [Related]
4. CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis.
Wang D; Zhang H; Liang J; Gu Z; Zhou Q; Fan X; Hou Y; Sun L
Cell Mol Immunol; 2010 Nov; 7(6):485-90. PubMed ID: 20729906
[TBL] [Abstract][Full Text] [Related]
5. Frequency of CD4+ regulatory T cells, CD8+ T cells, and human papilloma virus infection in Egyptian Women with breast cancer.
Tawfeik AM; Mora A; Osman A; Moneer MM; El-Sheikh N; Elrefaei M
Int J Immunopathol Pharmacol; 2020; 34():2058738420966822. PubMed ID: 33103515
[TBL] [Abstract][Full Text] [Related]
6. The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL).
Dehghani M; Shokrgozar N; Ramzi M; Kalani M; Golmoghaddam H; Arandi N
Cancer Immunol Immunother; 2021 Oct; 70(10):2961-2969. PubMed ID: 33721055
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV.
Chetty-Sebastian D; Assounga AG
BMC Cancer; 2023 Sep; 23(1):830. PubMed ID: 37670247
[TBL] [Abstract][Full Text] [Related]
8. Selective accumulation of differentiated FOXP3(+) CD4 (+) T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood.
Jandus C; Bioley G; Speiser DE; Romero P
Cancer Immunol Immunother; 2008 Dec; 57(12):1795-805. PubMed ID: 18414854
[TBL] [Abstract][Full Text] [Related]
9. Expression characteristics of peripheral lymphocyte programmed death 1 and FoxP3
Li H; Cao GM; Gu GL; Li SY; Yan Y; Fu Z; Du XH
World J Gastroenterol; 2023 Oct; 29(40):5582-5592. PubMed ID: 37970473
[TBL] [Abstract][Full Text] [Related]
10. Induction of CD4
Atwany NZ; Hashemi SK; Jayakumar MN; Nagarkatti M; Nagarkatti P; Hassuneh MR
Biology (Basel); 2020 Aug; 9(8):. PubMed ID: 32781652
[TBL] [Abstract][Full Text] [Related]
11. Altered frequency of FOXP3
Arandi N; Zekavat OR; Shokrgozar N; Shahsavani A; Golmoghaddam H; Kalani M
Int J Lab Hematol; 2023 Dec; 45(6):953-960. PubMed ID: 37488961
[TBL] [Abstract][Full Text] [Related]
12. Increased circulating regulatory T cells and decreased follicular T helper cells are associated with colorectal carcinogenesis.
Meng Q; Zhao Y; Xu M; Wang P; Li J; Cui R; Fu W; Ding S
Front Immunol; 2024; 15():1287632. PubMed ID: 38343544
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment.
Santagata S; Rea G; Castaldo D; Napolitano M; Capiluongo A; D'Alterio C; Trotta AM; Ieranò C; Portella L; Di Maro S; Tatangelo F; Albino V; Guarino R; Cutolo C; Izzo F; Scala S
Hepatol Int; 2024 Apr; 18(2):568-581. PubMed ID: 37142825
[TBL] [Abstract][Full Text] [Related]
14. Presence of FOXP3(+)Treg cells is correlated with colorectal cancer progression.
Liu Z; Huang Q; Liu G; Dang L; Chu D; Tao K; Wang W
Int J Clin Exp Med; 2014; 7(7):1781-5. PubMed ID: 25126180
[TBL] [Abstract][Full Text] [Related]
15. Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody.
Dao T; Mun SS; Scott AC; Jarvis CA; Korontsvit T; Yang Z; Liu L; Klatt MG; Guerreiro M; Selvakumar A; Brea EJ; Oh C; Liu C; Scheinberg DA
Oncoimmunology; 2019; 8(7):1570778. PubMed ID: 31143508
[TBL] [Abstract][Full Text] [Related]
16. Alteration of CD4CD25Foxp3 T cell level in Kawasaki disease.
Sohn SY; Song YW; Yeo YK; Kim YK; Jang GY; Woo CW; Lee JH; Lee KC
Korean J Pediatr; 2011 Apr; 54(4):157-62. PubMed ID: 21738549
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood regulatory B and T cells are decreased in patients with focal epilepsy.
Sanli E; Sirin NG; Kucukali CI; Baykan B; Ulusoy CA; Bebek N; Yilmaz V; Tuzun E
J Neuroimmunol; 2024 Feb; 387():578287. PubMed ID: 38241950
[TBL] [Abstract][Full Text] [Related]
18. Frequency of infiltrating regulatory T-cells in the portal tract of biliary atresia.
Oita S; Saito T; Hashimoto R; Fumita T; Katsumata Y; Terui K; Komatsu S; Takenouchi A; Ikeda JI; Hishiki T
Pediatr Surg Int; 2023 Sep; 39(1):259. PubMed ID: 37656274
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination.
Mukherjee S; Chakraborty S; Basak U; Pati S; Dutta A; Dutta S; Roy D; Banerjee S; Ray A; Sa G; Das T
Discov Oncol; 2023 Dec; 14(1):220. PubMed ID: 38038865
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients.
Ling KL; Pratap SE; Bates GJ; Singh B; Mortensen NJ; George BD; Warren BF; Piris J; Roncador G; Fox SB; Banham AH; Cerundolo V
Cancer Immun; 2007 Mar; 7():7. PubMed ID: 17388261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
